Pharma Insider Sells 4,772 Shares as 2025 Revenue Hits $883M
A high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
Explore various ways to build wealth for retirement at age 50. Take actionable steps toward financial success.
17,116 articlesA high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
AI growth stocks may ride the wave of innovation, but a stubborn helium shortage could cap upside. Even if Iran ends,...
AMD is grabbing attention as its stock soars. This guide breaks down the core drivers, the risks, and concrete steps ...
New documents reveal X and xAI landed a 10-year deal to share an Atlanta data center, with a $10.1 million property t...
IMDX kicked off 2026 with a solid Q1 showing, delivering revenue growth and improving margins while guiding higher fu...
A niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
ARK’s latest AI IPO move put Cerebras at the center of a hype-filled market. Before you copy a big bet, learn the rea...
Even with just $500, you can build a steady dividend stream. This guide highlights the smartest dividend stocks with ...
Meta Platforms surprised the market on Wednesday as investors rallied around news of new paid tier options and a broa...
Hostile shifts in homebuilder M&A are triggering a wave of talent departures and tighter loan terms. The ripple effec...
As AI accelerates, a pair of blue-chip picks stands out for a decade-long hold. Learn why these two AI leaders fit th...
A bold forecast surrounds Shiba Inu: that it will never reclaim its all-time high. This article breaks down the logic...